KEY PRODUCTS
ASolution Pharmaceuticals: Your CDMO Partner for APIs and Specialty Molecules.
01 1ASolution Pharmaceuticals
01 1SUGAMMADEX SODIUM
01 1India
01 1Active
01 1Complete
ASolution Pharmaceuticals: Your CDMO Partner for APIs and Specialty Molecules.
GDUFA
DMF Review : Complete
Rev. Date : 2023-02-14
Pay. Date : 2022-12-16
DMF Number : 37455
Submission : 2022-09-16
Status : Active
Type : II
20
Asolution Pharmaceuticals Pvt Ltd, based in India, is a pharmaceutical company.
They are recognized for ASolution Pharmaceuticals: Your CDMO Partner for APIs and Specialty Molecules.
One of their notable products is SUGAMMADEX SODIUM, with a corresponding US DMF Number 37455.
Remarkably, this DMF maintains an Active status since its submission on September 16, 2022, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of February 14, 2023, and payment made on December 16, 2022, indicating their dedication to facilitating drug approvals, Categorized as Type II
